Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Bone Marrow Transplantation|November 7, 2002
A phase I dose-escalation study of etoposide continuous infusion added to busulphan/cyclophosphamide as conditioning prior to autologous or allogeneic stem cell transplantationD S Ritchie, J Szer, A W Roberts, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2000
CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunityI F Hermans, D S Ritchie, J Yang, et al.
Bone Marrow Transplantation|August 11, 2001
Acute left ventricular failure following melphalan and fludarabine conditioningD S Ritchie, J F Seymour, A W Roberts, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
Impaired ability of MHC class II-/- dendritic cells to provide tumor protection is rescued by CD40 ligationI F Hermans, D S Ritchie, A Daish, et al.
Bone Marrow Transplantation|January 8, 2008
Cyclosporin, methotrexate and prednisolone for graft-versus-host disease prophylaxis in allogeneic peripheral blood progenitor cell transplantsR Hoyt, D S Ritchie, A W Roberts, et al.
Internal Medicine Journal|June 4, 2016
Nephrotic syndrome as a complication of chronic graft-versus-host disease after allogeneic haemopoietic stem cell transplantationE Wong, M Lasica, S Z He, et al.
Annals of Hematology|November 8, 2006
The hyper-CVAD-rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphomaD S Ritchie, J F Seymour, A P Grigg, et al.
Internal Medicine Journal|January 29, 2011
Use of antibacterial prophylaxis for patients with neutropenia. Australian Consensus Guidelines 2011 Steering CommitteeM A Slavin, S Lingaratnam, L Mileshkin, et al.
Journal of Immunological Methods|December 21, 2000
Dendritic cell elimination as an assay of cytotoxic T lymphocyte activity in vivoD S Ritchie, I F Hermans, J M Lumsden, et al.
Internal Medicine Journal|July 1, 2008
Diagnostic and therapeutic approach to persistent or recurrent fevers of unknown origin in adult stem cell transplantation and haematological malignancyC O Morrissey, P G Bardy, M A Slavin, et al.
Pageof 4